Critics raise concern about direct-to-consumer genetic tests
October 9th, 2010 - 1:29 pm ICT by ANIWashington, Oct 09 (ANI): Critics have raised concern about the safety risks of Direct-to-consumer (DTC) genetic tests available from retailers and the Internet, which let people learn about their genomes without going to a doctor.
These test raise the question of who is responsible for oversight and regulation of these DTC tests.
Even critics worry about safety risks if consumers base important lifestyle or medical decisions on inaccurate or misunderstood test results.
A group of four leading bioethical, legal and medical researchers believes the solution will require an innovative approach that combines premarket studies done before tests enter the market with ongoing postmarket evaluations to confirm how well tests perform once they are in use.
Because DTC tests move in a global Internet marketplace, close international cooperation also will be required.
The team, led by Amy L. McGuire of the Center for Medical Ethics and Health Policy at Baylor College of Medicine in Houston, also include Barbara Evans of the University of Houston (UH) Law Center, Canadian legal expert Timothy Caulfield and Wylie Burke, M.D., of the University of Washington School of Medicine.
In their Science article, the authors note that more than 90 percent of the genetic tests now available in the United States have never been through a regulatory review to prove the tests are safe and actually improve human health.
A broad consensus exists for some form of regulatory review before new tests enter the market, but potential solutions have been mired in controversy.
There are practical barriers to forcing all new genetic tests to go through the same sort of data-intensive premarket review the Food & Drug Administration requires for other medical products, such as drugs.
“We favor a risk-stratified approach that tailors the regulatory requirements to the level of risk a DTC test actually presents,” said Evans, who is also co-director of UH’s Health Law & Policy Institute.
The group’s policy recommendations for DTC genetic tests appear in the Oct. 8 issue of Science magazine, the world’s leading journal of original scientific research, global news and commentary. (ANI)
- Unrealistic claims of home genetic tests should be avoided - Aug 19, 2010
- DIY DNA tests tell couples about their unborn baby's genetic disease risk - Mar 27, 2011
- Analyzing family health history 'best way for disease risk assessment' - Nov 06, 2010
- 'Know your genes to live hale and hearty' - Jan 11, 2012
- Obama names Indian American to White House bioethics panel - Apr 10, 2010
- Study reveals possible interventions for cancer, obesity - Jan 11, 2011
- Doctors 'should quiz patients about sexual life' - Sep 25, 2010
- Chaka Khan says that Whitney Houston was a friend and a little sister - Feb 15, 2012
- Crying babies 'likelier to have behavioural problems in childhood' - Apr 21, 2011
- US Govt 'to regulate e-cigarettes as tobacco' - Apr 26, 2011
- Viagra 'doesn't work for men with low testosterone' - Sep 25, 2010
- China to penalise people found spreading STDs - May 21, 2011
- Simple blood test to detect Down's syndrome cuts miscarriage risk - Mar 07, 2011
- China most likely to be affected by 2011 EU herbal medicine ban - Dec 30, 2010
- Australia to end IELTS monopoly for student visas - Oct 17, 2011
Tags: barbara evans, baylor college of medicine, baylor college of medicine in houston, college of medicine, genetic tests, genomes, global internet marketplace, international cooperation, legal expert, medical decisions, medical ethics, medical researchers, potential solutions, safety risks, school of medicine, science article, timothy caulfield, uh law center, university of washington school of medicine, wylie burke